Be the first to receive investor updates.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce tortor nulla, efficitur at magna sed, gravida venenatis lectus. Sed viverra est ac lectus viverra, condimentum efficitur metus condimentum.

Success! Your contact information has been successfully added to Clearmind Medicine's list.

Oops! Something went wrong while subscribing. Please try again.

Support Life-Changing Treatments

Invest in Clearmind and help develop new medicines, designed to help people who suffer from mental health issues and binge behaviours.

Invest in Clearmind

Company Highlights

A Mature IP Portfolio, Innovative R&D, and Solid Financial Backbone

Patent Filings

6 Patents families

22 patents filed or granted

Patent filing program

Novel psychedelic compounds

Integration of delivery platforms

Methods of use in psychiatric indications

Drug discovery pipeline

Scientific

15 different drug research programs

Targeting various indications such as Alcohol Use Disorder, depression, eating disorders and other binge behaviours

Demonstrated safety POC of proprietary AUD molecule designed to be shorter acting, more scalable and accessible

Pre-clinical studies progressing lead programs towards IND filings and Phase I/II clinical studies

Partnership with leading universities & KOL's

Financial

C$9.4 M raised to date. Well-funded to progress clinical trial and IP strategies

Strategic shareholders including top Israeli institutional funds

CSE – Commenced trading in May 2021

FSE – Commenced trading in August 2021

OTC – Commenced trading in November 2021

Fully eligible for settlement through the DTC January 2022

Why We’re Different

We develop our proprietary treatments to be self-administered and show immediate results.

The information presented in this table is based solely on the Company’s own market research. Actual information may contradict the Company’s findings.

The Opportunity

The market of alcohol-related psychedelic treatments has low competitive density.

1.6%

of clinical trials are
alcohol-related

There are only 21 Alcohol related clinical trials,

... out of a total of 1302 registered clinical trials of psychedelics.

This information is based on the clinical studies available on clinicaltrials.gov

Investor Information

Learn more about Clearmind’s unique approach and strategy.

SEDAR Filings
View
Corporate Presentation
Download

Investor Frequently Asked Questions

How can I invest in Clearmind?

What is Clearmind’s fiscal year?

How does Clearmind prepare their financial statements?

Does Clearmind pay any dividends?

When will the next financials be released?

Join Us

Let's Make History

Information

Reason for Inquiry

Thank you for sending your contact information—your details have been received.

Oops! Something went wrong. Please try again.